Megha M Vasavada1, Jianli Wang1, Paul J Eslinger2, David J Gill3, Xiaoyu Sun1, Prasanna Karunanayaka1, Qing X Yang4. 1. Department of Radiology, Pennsylvania State University College of Medicine, Hershey, PA, USA. 2. Department of Radiology, Pennsylvania State University College of Medicine, Hershey, PA, USA Department of Neurology, Pennsylvania State University College of Medicine, Hershey, PA, USA Department of Neural & Behavioral Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA. 3. Unity Rehabilitation and Neurology at Ridgeway, Rochester, NY, USA. 4. Department of Radiology, Pennsylvania State University College of Medicine, Hershey, PA, USA Department of Neurosurgery, Pennsylvania State University College of Medicine, Hershey, PA, USA.
Abstract
BACKGROUND: Olfactory deficits are prevalent in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). These symptoms precede clinical onset of cognitive and memory deficits and coincide with AD pathology preferentially in the central olfactory structures, suggesting a potential biomarker for AD early detection and progression. OBJECTIVE: Therefore, we tested the hypothesis that structural degeneration of the primary olfactory cortex (POC) could be detected in AD as well as in MCI patients and would be correlated with olfactory functional magnetic resonance imaging (fMRI) alterations, reflecting loss of olfactory cortex activity. METHODS: Total structural volumes and fMRI activation volumes of the POC and hippocampus were measured along with olfactory and cognitive behavioral tests in 27 cognitively normal (CN), 21 MCI, and 15 AD subjects. RESULTS: Prominent atrophy in the POC and hippocampus was found in both AD and MCI subjects and correlated with behavioral measurements. While behavioral and volumetric measurements showed a gradual decline from CN to MCI to AD, olfactory activation volume in the POC and hippocampus showed a steeper decline in the MCI group compared to corresponding tissue volume, resembling the AD group. CONCLUSIONS: Decline in olfactory activity was correlated with the AD structural degeneration in the POC. A more prominent olfactory activity deficit than that of behavioral and tissue volume measurements was shown in the MCI stage. Olfactory fMRI may thus provide an earlier and more sensitive measure of functional neurodegeneration in AD and MCI patients.
BACKGROUND: Olfactory deficits are prevalent in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). These symptoms precede clinical onset of cognitive and memory deficits and coincide with AD pathology preferentially in the central olfactory structures, suggesting a potential biomarker for AD early detection and progression. OBJECTIVE: Therefore, we tested the hypothesis that structural degeneration of the primary olfactory cortex (POC) could be detected in AD as well as in MCI patients and would be correlated with olfactory functional magnetic resonance imaging (fMRI) alterations, reflecting loss of olfactory cortex activity. METHODS: Total structural volumes and fMRI activation volumes of the POC and hippocampus were measured along with olfactory and cognitive behavioral tests in 27 cognitively normal (CN), 21 MCI, and 15 AD subjects. RESULTS: Prominent atrophy in the POC and hippocampus was found in both AD and MCI subjects and correlated with behavioral measurements. While behavioral and volumetric measurements showed a gradual decline from CN to MCI to AD, olfactory activation volume in the POC and hippocampus showed a steeper decline in the MCI group compared to corresponding tissue volume, resembling the AD group. CONCLUSIONS: Decline in olfactory activity was correlated with the AD structural degeneration in the POC. A more prominent olfactory activity deficit than that of behavioral and tissue volume measurements was shown in the MCI stage. Olfactory fMRI may thus provide an earlier and more sensitive measure of functional neurodegeneration in AD and MCI patients.
Authors: David R Roalf; Madelyn J Moberg; Bruce I Turetsky; Laura Brennan; Sushila Kabadi; David A Wolk; Paul J Moberg Journal: J Neurol Neurosurg Psychiatry Date: 2016-12-30 Impact factor: 10.154
Authors: Lei Du; Fang Liu; Kefei Liu; Xiaohui Yao; Shannon L Risacher; Junwei Han; Andrew J Saykin; Li Shen Journal: IEEE Trans Med Imaging Date: 2020-10-28 Impact factor: 10.048
Authors: Jianli Wang; Sebastian Rupprecht; Xiaoyu Sun; Diana Freiberg; Courtney Crowell; Emma Cartisano; Megha Vasavada; Qing X Yang Journal: J Vis Exp Date: 2017-07-30 Impact factor: 1.355
Authors: Megan Quarmley; Paul J Moberg; Dawn Mechanic-Hamilton; Sushila Kabadi; Steven E Arnold; David A Wolk; David R Roalf Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Lei Du; Kefei Liu; Xiaohui Yao; Shannon L Risacher; Junwei Han; Andrew J Saykin; Lei Guo; Li Shen Journal: IEEE/ACM Trans Comput Biol Bioinform Date: 2021-02-03 Impact factor: 3.710